Evaluation of the Effects of systemic Therapy on Inflammatory Markers and Disease Severity in Patients With Pemphigus

Evaluation of the Effects of systemic Therapy on Inflammatory Markers and Disease Severity in Patients With Pemphigus

Authors

Keywords:

IVIG, remission, pemphigus, inflammatory markers

Abstract

Introduction: In recent years, various inflammatory markers that can change in inflammatory states have been investigated. On the basis of these, we thought that inflammatory markers could also be used in the treatment of pemphigus disease and monitoring its activity.

Objective: In this study, our objective was to investigate changes in the inflammatory markers NLR, PLR, MPV, LMR, CRP and ESR, which are inflammatory markers, before treatment and during follow-up, and the correlation of disease severity with these markers in patients with pemphigus receiving IVIG and/or systemic immunosuppressant agents.

Method: 76 pemphigus patients who received systemic treatment, and used these treatments for at least 6 months were included. Changes in NLR, PLR, LMR, MPV, CRP and sedimentation values were examined in patients who received systemic treatment for at least 6 months, before the start of treatment and 3 and 6 months after the start of treatment.

Results: Significant changes in inflammatory markers and correlation values were found in all patients.

Conclusions: We think that neutrophil, platelet, NLR and PLR values can be used to monitor the response to treatment in pemphigus, since they show a significant decrease with treatment and are significantly positively correlated with PDAI, which indicates the severity of the disease. LMR values were indicators of a poor prognosis. We found that the duration of remission was longer in the group receiving IVIg. Although there was no difference between the treatments in terms of disease recovery, only IVIg prolonged the duration of remission.

References

Schmidt E, Kasperkiewicz M, Joly P. Pemphigus. Lancet. 2019;394(10201):882-894. DOI: 10.1016/S0140-6736(19)31778-7. PMID: 31498102.

Porro AM, Caetano Lde V, Maehara Lde S, Enokihara MM. Non-classical forms of pemphigus: pemphigus herpetiformis, IgA pemphigus, paraneoplastic pemphigus and IgG/IgA pemphigus. An Bras Dermatol. 2014;89(1):96-106. DOI:10.1590/abd1806-4841.20142459 PMID:24626654

Chen L, Deng H, Cui H, et al. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget. 2018;9(6):7204-18. DOI:10.18632/oncotarget.23208 PMID:29467962

Bartneck M, Wang J. Therapeutic Targeting of Neutrophil Granulocytes in Inflammatory Liver Disease. Front Immunol. 2019;10:2257. DOI:10.3389/fimmu.2019.02257 PMID:31616430

Yoon CI, Park S, Cha YJ, et al. Associations between absolute neutrophil count and lymphocyte-predominant breast cancer. Breast. 2020;50:141-8. DOI:10.1016/j.breast.2019.09.013 PMID:31607527

Zhu X, Chen Y, Cui Y. Absolute Neutrophil Count and Mean Platelet Volume in the Blood as Biomarkers to Detect Lung Cancer. Dis Markers. 2020;2020:1371964. DOI:10.1155/2020/1371964 PMID:32377267

Katoh N. Platelets as versatile regulators of cutaneous inflammation. J Dermatol Sci. 2009;53(2):89-95. DOI:10.1016/j.jdermsci.2008.08.019 PMID:18922681

Dan K, Gomi S, Inokuchi K, et al. Effects of interleukin-1 and tumor necrosis factor on megakaryocytopoiesis: mechanism of reactive thrombocytosis. Acta Haematol. 1995;93(2-4):67-72. DOI:10.1159/000204114 PMID:7639054

Leblanc R, Peyruchaud O. Metastasis: new functional implications of platelets and megakaryocytes. Blood. 2016;128(1):24-31. DOI:10.1182/blood-2016-01-636399 PMID:27154188

Bednarz-Knoll N, Popęda M, Kryczka T, et al. Higher platelet counts correlate to tumour progression and can be induced by intratumoural stroma in non-metastatic breast carcinomas. Br J Cancer. 2022;126(3):464-71. DOI:10.1038/s41416-021-01647-9 PMID:34857895

Kim KH, Park TY, Lee JY, et al. Prognostic significance of initial platelet counts and fibrinogen level in advanced non-small cell lung cancer. J Korean Med Sci. 2014;29(4):507-11. DOI:10.3346/jkms.2014.29.4.507 PMID:24753697

Shen H, Xu C, Chen C. [Platelet count predicts therapeutic response of infliximab for active Crohn's disease]. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2016;45(1):81-5. DOI:10.3785/j.issn.1008-9292.2016.01.13 PMID:27045246

Willeke P, Kümpers P, Schlüter B, Limani A, Becker H, Schotte H. Platelet counts as a biomarker in ANCA-associated vasculitis. Scand J Rheumatol. 2015;44(4):302-8. DOI:10.3109/03009742.2015.1006247 PMID:25744854

Tamer F, Gulekon A. Novel Inflammatory Biomarkers in Patients with Mycosis Fungoides Treated with Bexarotene. J Coll Physicians Surg Pak. 2021;31(6):716-8. DOI:10.29271/jcpsp.2021.06.716 PMID:34102787

Murrell DF, Dick S, Ahmed AR, et al. Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus. J Am Acad Dermatol. 2008;58(6):1043-6. DOI:10.1016/j.jaad.2008.01.012 PMID:18339444

Hertl M, Jedlickova H, Karpati S, et al. Pemphigus. S2 Guideline for diagnosis and treatment--guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV). J Eur Acad Dermatol Venereol. 2015;29(3):405-14. DOI:10.1111/jdv.12772 PMID:25338479

Park SH, Lee SH, Kim JH, Kim SC. Circulating Eosinophil and Neutrophil Counts Correlate with Disease Severity in Bullous Pemphigoid. Ann Dermatol. 2018;30(5):544-9. DOI:10.5021/ad.2018.30.5.544 PMID:33911476

Ameglio F, D'Auria L, Cordiali-Fei P, et al. Anti-intercellular substance antibody log titres are correlated with serum concentrations of interleukin-6, interleukin-15 and tumor necrosis factor-alpha in patients with Pemphigus vulgaris relationships with peripheral blood neutrophil counts, disease severity and duration and patients' age. J Biol Regul Homeost Agents. 1999;13(4):220-4. PMID:10703946

Yuan H, Zhou S, Liu Z, et al. Pivotal Role of Lesional and Perilesional T/B Lymphocytes in Pemphigus Pathogenesis. J Invest Dermatol. 2017;137(11):2362-70. DOI:10.1016/j.jid.2017.05.032 PMID:28647348

El-Naby SM, Amin MM, Ali MA, Gaballah MA. Evaluation of the relation between T-Lymphocytes (CD4 + ve and CD8 + ve) and pemphigus vulgaris pathogenesis and severity. Indian J Dermatopathol Diagn Dermatol 2019;6:30-5 DOI: 10.4103/ijdpdd.ijdpdd_70_18

Kowalska-Kępczyńska A, Mleczko M, Domerecka W, Krasowska D, Donica H. Assessment of Immune Cell Activation in Pemphigus. Cells. 2022;11(12):1912. DOI:10.3390/cells11121912 PMID:35741041

Yang Z, Zhang Z, Lin F, et al. Comparisons of neutrophil-, monocyte-, eosinophil-, and basophil- lymphocyte ratios among various systemic autoimmune rheumatic diseases. APMIS. 2017;125(10):863-71. DOI:10.1111/apm.12722 PMID:28766758

Al-Osami MH, Awadh NI, Khalid KB, Awadh AI. Neutrophil/lymphocyte and platelet/lymphocyte ratios as potential markers of disease activity in patients with Ankylosing spondylitis: a case-control study. Adv Rheumatol. 2020;60(1):13. DOI:10.1186/s42358-020-0113-5 PMID:32000859

Mercan R, Bitik B, Tufan A, et al. The Association Between Neutrophil/Lymphocyte Ratio and Disease Activity in Rheumatoid Arthritis and Ankylosing Spondylitis. J Clin Lab Anal. 2016;30(5):597-601. DOI:10.1002/jcla.21908 PMID:26666737

Langley BO, Guedry SE, Goldenberg JZ, Hanes DA, Beardsley JA, Ryan JJ. Inflammatory Bowel Disease and Neutrophil-Lymphocyte Ratio: A Systematic Scoping Review. J Clin Med. 2021;10(18):4219. DOI:10.3390/jcm10184219 PMID:34575330

Najjar M, Agrawal S, Emond JC, Halazun KJ. Pretreatment neutrophil-lymphocyte ratio: useful prognostic biomarker in hepatocellular carcinoma. J Hepatocell Carcinoma. 2018;5:17-28. DOI:10.2147/JHC.S86792 PMID:29404284

Tang H, Lu W, Li B, Li C, Xu Y, Dong J. Prognostic significance of neutrophil-to-lymphocyte ratio in biliary tract cancers: a systematic review and meta-analysis. Oncotarget. 2017;8(22):36857-68.

Marazziti D, Torrigiani S, Carbone MG, et al. Neutrophil/Lymphocyte, Platelet/Lymphocyte, and Monocyte/Lymphocyte Ratios in Mood Disorders. Curr Med Chem. 2022;29(36):5758-81. DOI:10.2174/0929867328666210922160116 PMID:34551689

Şereflican B, Parlak AH. Clinical, Demographical Features, Accompanying Diseases and Neutrophil to Lymphocyte Ratio- Platelet to Lymphocyte Ratio in Patients with Bullous Pemphigoid in Bolu. Cumhur Med J. 2019; 41(1):88-93. https://doi.org/10.7197/223.vi.475189

Wang WM, Jin HZ. Role of Neutrophils in Psoriasis. J Immunol Res. 2020;2020:3709749. DOI:10.1155/2020/3709749 PMID:32587871

Ataş H, Cemil BÇ, Kurmuş GI, Gönül M. Assessment of systemic inflammation with neutrophil-lymphocyte ratio in lichen planus. Postepy Dermatol Alergol. 2016;33(3):188-92. DOI:10.5114/pdia.2016.56930 PMID:27512353

UÇMAK D, AKKURT M, UÇAK H, ARICA M Nötrofil/lenfosit Oranının Pemfigus Vulgaris ile İlişkisi. KONURALP TIP DERGİSİ. 2015; 7(2): 88 - 92.

Lyakhovitsky A, Dascalu J, Drousiotis T, Barzilai A, Baum S. Hematological Inflammatory Markers in Patients with Pemphigus Vulgaris. Dermatology. 2021;237(6):912-20. DOI:10.1159/000512916 PMID:33472194

Gasparyan AY, Ayvazyan L, Mukanova U, Yessirkepov M, Kitas GD. The Platelet-to-Lymphocyte Ratio as an Inflammatory Marker in Rheumatic Diseases. Ann Lab Med. 2019;39(4):345-57. DOI:10.3343/alm.2019.39.4.345 PMID:30809980

Hayta S, Güner R, Akyol M. Blood mean platelet volume may be predictive for disease course in the cases with pemphigus vulgaris. Biomed Res (Aligarh). 2017;9(28):4223–7.36)

Rajwa P, Życzkowski M, Paradysz A, Bujak K, Bryniarski P. Evaluation of the prognostic value of LMR, PLR, NLR, and dNLR in urothelial bladder cancer patients treated with radical cystectomy. Eur Rev Med Pharmacol Sci. 2018;22(10):3027-37. DOI:10.26355/eurrev_201805_15060 PMID:29863247

Ma Y, Zhang J, Chen X. Lymphocyte-to-Monocyte Ratio is Associated with the Poor Prognosis of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy. Cancer Manag Res. 2021;13:1571-80. DOI:10.2147/CMAR.S292048 PMID:33623436

Liu X, Li M, Zhao F, et al. The lymphocyte-monocyte ratio predicts tumor response and survival in patients with locally advanced esophageal cancer who received definitive chemoradiotherapy. Onco Targets Ther. 2017;10:871-7. DOI:10.2147/OTT.S124915 PMID:28243122

Sirin MC, Korkmaz S, Erturan I, et al. Evaluation of monocyte to HDL cholesterol ratio and other inflammatory markers in patients with psoriasis. An Bras Dermatol. 2020;95(5):575-82. DOI:10.1016/j.abd.2020.02.008 PMID:32711928

Svecova D. IVIG therapy in pemphigus vulgaris has corticosteroid-sparing and immunomodulatory effects. Australas J Dermatol. 2016;57(2):141-4. DOI:10.1111/ajd.12422 PMID:26581165

Downloads

Published

2025-01-29

How to Cite

1.
Güner ME, Ozturk P, Kuş M müjde. Evaluation of the Effects of systemic Therapy on Inflammatory Markers and Disease Severity in Patients With Pemphigus. Dermatol Pract Concept. 2025;15(1):4969. doi:10.5826/dpc.1501a4969

Share